Business
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine
About this update from Cardio Diagnostics Holdings Inc.
[{"type":"text","content":" CHICAGO--(BUSINESS WIRE)--\nCardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that Meesha Dogan, Ph.D., CEO of Cardio Diagnostics, will present at the following investor conferences:\n\n\nH.C. Wainwright 25th Annual Global Investment Conference\nDate: September 11-13, 2023\nCDIO Presentation: September 13, 2023\nVenue: Lotte New York Palace Hotel in New York City, NY\n\n\nNorthland Capital Markets Institutional Investor Conference\nDate: September 19, 2023\nVenue: Virtual\n\n\nManagement is scheduled to participate in one-on-one meetings with institutional analysts and investors at these conferences. CDIO’s presentation has been filed as an 8-K with the SEC.\n\n\nAbout Cardio Diagnostics Holdings, Inc\n\n\nCardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit www.cardiodiagnosticsinc.com.\n\n\nForward-Looking Statements\n\n\nCertain statements and information included in this press release constitute \"forward-looking statements\" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, \"will likely result,\" \"expected to,\" \"will continue,\" \"anticipated,\" \"estimate,\" \"projected,\" \"intend,\" “goal,” or similar expressions are intended to identify \"forward-looking statements\" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, dilution to stockholders...